OBJECTIVE: To assess opinions, knowledge, and informational resources of obstetrician-gynaecologists regarding the safety of medication use during pregnancy. METHODS: A questionnaire was mailed to 770 members of the American College of Obstetricians and Gynecologists who participate in the Collaborative Ambulatory Research Network. RESULTS: The response rate was 58%. Of these, 305 respondents provide both routine gynecologic and obstetric care and are the focus of the study. There was wide variation in obstetrician-gynaecologists' assessments of the safety for the foetus of medications ranging from aspirin to valproic acid. The Physicians' Desk Reference was most frequently (75%) cited as a source of information about medication safety. Forty-two percent of obstetrician-gynaecologists selected lack of sufficient information on medications as the greatest barrier to counselling pregnant women about their use, while only 4% selected lack of access to information as the greatest barrier. Most (79%) obstetrician-gynaecologists indicated they would be willing to participate in pregnancy exposure registries, but far fewer (24%) reported having done so. CONCLUSION: These results emphasise the need for safety information about the effects of medication use during pregnancy and suggest that pregnancy exposure registries are underutilised.
OBJECTIVE: To assess opinions, knowledge, and informational resources of obstetrician-gynaecologists regarding the safety of medication use during pregnancy. METHODS: A questionnaire was mailed to 770 members of the American College of Obstetricians and Gynecologists who participate in the Collaborative Ambulatory Research Network. RESULTS: The response rate was 58%. Of these, 305 respondents provide both routine gynecologic and obstetric care and are the focus of the study. There was wide variation in obstetrician-gynaecologists' assessments of the safety for the foetus of medications ranging from aspirin to valproic acid. The Physicians' Desk Reference was most frequently (75%) cited as a source of information about medication safety. Forty-two percent of obstetrician-gynaecologists selected lack of sufficient information on medications as the greatest barrier to counselling pregnant women about their use, while only 4% selected lack of access to information as the greatest barrier. Most (79%) obstetrician-gynaecologists indicated they would be willing to participate in pregnancy exposure registries, but far fewer (24%) reported having done so. CONCLUSION: These results emphasise the need for safety information about the effects of medication use during pregnancy and suggest that pregnancy exposure registries are underutilised.
Authors: Crystal P Tyler; Nigel Paneth; Elizabeth N Allred; Deborah Hirtz; Karl Kuban; Thomas McElrath; T Michael O'Shea; Cindy Miller; Alan Leviton Journal: Am J Obstet Gynecol Date: 2012-07-07 Impact factor: 8.661
Authors: Molly M Lynch; Jacqueline B Amoozegar; Emily M McClure; Linda B Squiers; Cheryl S Broussard; Jennifer N Lind; Kara N Polen; Meghan T Frey; Suzanne M Gilboa; Janis Biermann Journal: Qual Health Res Date: 2017-10-03
Authors: Elizabeth C Ailes; John Zimmerman; Jennifer N Lind; Fanghui Fan; Kun Shi; Jennita Reefhuis; Cheryl S Broussard; Meghan T Frey; Janet D Cragan; Emily E Petersen; Kara D Polen; Margaret A Honein; Suzanne M Gilboa Journal: Matern Child Health J Date: 2020-07
Authors: Michelle Sophie Keller; Sasan Mosadeghi; Erica R Cohen; James Kwan; Brennan Mason Ross Spiegel Journal: J Med Internet Res Date: 2018-06-11 Impact factor: 5.428
Authors: Ziyad Alrabiah; Mohamed N Al-Arifi; Sultan M Alghadeer; Syed Wajid; Ali AlQahtani; Naif Almotari; AbdAllh AlHwerani; Salmeen D Babelghaith Journal: Saudi Pharm J Date: 2017-05-25 Impact factor: 4.330